{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:07:55Z","timestamp":1792782475126,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Aarhus University Hospital","id":[{"id":"https:\/\/ror.org\/040r8fr65","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"DOI":"10.1007\/s00198-026-08206-z","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:30:27Z","timestamp":1789093827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic glucocorticoid use increases fracture risk similarly in individuals with and without type 2 diabetes: a Danish nationwide cohort study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1201-199X","authenticated-orcid":false,"given":"Zheer K","family":"Al-Mashhadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke","family":"Viggers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Starup-Linde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente L","family":"Langdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"van Hulten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop P","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna HM","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Gregersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"issue":"4","key":"8206_CR1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2014a meta-analysis. Osteoporos Int 18(4):427\u2013444. https:\/\/doi.org\/10.1007\/s00198-006-0253-4","journal-title":"Osteoporos Int"},{"issue":"10","key":"8206_CR2","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00592-018-1187-y","volume":"55","author":"A Valentini","year":"2018","unstructured":"Valentini A, Cianfarani MA, De Meo L, Morabito P, Romanello D, Tarantino U et al (2018) FRAX tool in type 2 diabetic subjects: the use of HbA1c in estimating fracture risk. Acta Diabetol 55(10):1043\u20131050. https:\/\/doi.org\/10.1007\/s00592-018-1187-y","journal-title":"Acta Diabetol"},{"issue":"6","key":"8206_CR3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s11914-020-00638-8","volume":"18","author":"Z Al-Mashhadi","year":"2020","unstructured":"Al-Mashhadi Z, Viggers R, Fuglsang-Nielsen R, de Vries F, van den Bergh JP, Harsl\u00f8f T et al (2020) Glucose-lowering drugs and fracture risk\u2014a systematic review. Curr Osteoporos Rep 18(6):737\u2013758. https:\/\/doi.org\/10.1007\/s11914-020-00638-8","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"8206_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1749-6632.2002.tb04204.x","volume":"966","author":"E Canalis","year":"2002","unstructured":"Canalis E, Delany AM (2002) Mechanisms of glucocorticoid action in bone. Ann N Y Acad Sci 966(1):73\u201381. https:\/\/doi.org\/10.1111\/j.1749-6632.2002.tb04204.x","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"8206_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.pmrj.2011.02.017","volume":"3","author":"R Mitra","year":"2011","unstructured":"Mitra R (2011) Adverse effects of corticosteroids on bone metabolism: a review. PM R 3(5):466\u2013471. https:\/\/doi.org\/10.1016\/j.pmrj.2011.02.017","journal-title":"PM R"},{"key":"8206_CR6","doi-asserted-by":"publisher","DOI":"10.21926\/obm.geriatr.2002123","author":"Z Al-Mashhadi","year":"2020","unstructured":"Al-Mashhadi Z, Viggers R, Fuglsang-Nielsen R, Langdahl BL, Vestergaard P, Gregersen S et al (2020) Bone health in the elderly with type 2 diabetes mellitus: a systematic review. OBM Geriatr. https:\/\/doi.org\/10.21926\/obm.geriatr.2002123","journal-title":"OBM Geriatr"},{"issue":"7","key":"8206_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/1753-0407.12631","volume":"10","author":"MAM Rogers","year":"2018","unstructured":"Rogers MAM, Lin P, Nallamothu BK, Kim C, Waljee AK (2018) Longitudinal study of short-term corticosteroid use by working-age adults with diabetes mellitus: risks and mitigating factors. J Diabetes 10(7):546\u2013555. https:\/\/doi.org\/10.1111\/1753-0407.12631","journal-title":"J Diabetes"},{"issue":"12","key":"8206_CR8","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E Von Elm","year":"2014","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 12(12):1495\u20131499. https:\/\/doi.org\/10.1016\/j.ijsu.2014.07.013","journal-title":"Int J Surg"},{"issue":"8","key":"8206_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","volume":"29","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Pedersen L, S\u00f8rensen HT (2014) The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol 29(8):541\u2013549. https:\/\/doi.org\/10.1007\/s10654-014-9930-3","journal-title":"Eur J Epidemiol"},{"key":"8206_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2147\/CLEP.S179083","volume":"11","author":"M Schmidt","year":"2019","unstructured":"Schmidt M, Schmidt SAJ, Adelborg K, Sundb\u00f8ll J, Laugesen K, Ehrenstein V et al (2019) The Danish health care system and epidemiological research: from health care contacts to database records. CLEP 11:563\u2013591. https:\/\/doi.org\/10.2147\/CLEP.S179083","journal-title":"CLEP"},{"issue":"2","key":"8206_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","volume":"106","author":"K Furu","year":"2010","unstructured":"Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, S\u00f8rensen HT (2010) The Nordic Countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 106(2):86\u201394. https:\/\/doi.org\/10.1111\/j.1742-7843.2009.00494.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"7_suppl","key":"8206_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1403494810394717","volume":"39","author":"H Wallach Kildemoes","year":"2011","unstructured":"Wallach Kildemoes H, Toft S\u00f8rensen H, Hallas J (2011) The Danish National Prescription Registry. Scand J Public Health 39(7_suppl):38\u201341. https:\/\/doi.org\/10.1177\/1403494810394717","journal-title":"Scand J Public Health"},{"issue":"3","key":"8206_CR13","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/ije\/dyw213","volume":"46","author":"A Potteg\u00e5rd","year":"2017","unstructured":"Potteg\u00e5rd A, Schmidt SAJ, Wallach-Kildemoes H, S\u00f8rensen HT, Hallas J, Schmidt M (2017) Data resource profile: the Danish National Prescription Registry. Int J Epidemiol 46(3):798\u2013798f. https:\/\/doi.org\/10.1093\/ije\/dyw213","journal-title":"Int J Epidemiol"},{"issue":"7","key":"8206_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"17","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, S\u00f8rensen HT (2015) The Danish National Patient Registry: a review of content, data quality, and research potential. CLEP 17(7):449\u2013490. https:\/\/doi.org\/10.2147\/CLEP.S91125","journal-title":"CLEP"},{"key":"8206_CR15","unstructured":"Statistics Denmark. DOD - D\u00f8de i Danmark [Internet]. [cited 2025 Jun 17]. Available from: https:\/\/www.dst.dk\/extranet\/ForskningVariabellister\/DOD%20-%20D%C3%B8de%20i%20Danmark.html"},{"key":"8206_CR16","unstructured":"Statistics Denmark. VNDS - Historiske vandringer [Internet]. [cited 2025 Jun 17]. Available from: https:\/\/www.dst.dk\/extranet\/ForskningVariabellister\/VNDS%20-%20Historiske%20vandringer.html"},{"issue":"7_suppl","key":"8206_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1403494811405098","volume":"39","author":"M Baadsgaard","year":"2011","unstructured":"Baadsgaard M, Quitzau J (2011) Danish registers on personal income and transfer payments. Scand J Public Health 39(7_suppl):103\u2013105. https:\/\/doi.org\/10.1177\/1403494811405098","journal-title":"Scand J Public Health"},{"key":"8206_CR18","unstructured":"Statistics Denmark. FAIN - Husstande og familier [Internet]. [cited 2025 Jun 17]. Available from: https:\/\/www.dst.dk\/extranet\/ForskningVariabellister\/FAIN%20-%20Husstande%20og%20familier.html"},{"key":"8206_CR19","unstructured":"The National Centre for Register-based Research. The Employment Classification Module (AKM) [Internet]. [cited 2025 Jun 17]. Available from: https:\/\/ncrr.au.dk\/danish-registers\/the-employment-classification-module-akm"},{"key":"8206_CR20","unstructured":"World Health Organization Collaborating Centre for Drug Statistics Methodology. ATCDDD - Definition and general considerations [Internet]. [cited 2025 Jun 17]. Available from: https:\/\/atcddd.fhi.no\/ddd\/definition_and_general_considera\/"},{"issue":"5","key":"8206_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"issue":"25","key":"8206_CR22","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC (2009) Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity\u2010score matched samples. Stat Med 28(25):3083\u20133107. https:\/\/doi.org\/10.1002\/sim.3697","journal-title":"Stat Med"},{"key":"8206_CR23","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"2009","unstructured":"Cohen J (2009) Statistical power analysis for the behavioral sciences, 2. ed., reprint. Psychology Press, New York, NY","edition":"2. ed., reprint"},{"issue":"7","key":"8206_CR24","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/jech.2004.029496","volume":"60","author":"MA Hernan","year":"2006","unstructured":"Hernan MA (2006) Estimating causal effects from epidemiological data. J Epidemiol Community Health 60(7):578\u2013586. https:\/\/doi.org\/10.1136\/jech.2004.029496","journal-title":"J Epidemiol Community Health"},{"issue":"6","key":"8206_CR25","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/01.EDE.0000081989.82616.7d","volume":"14","author":"T Sato","year":"2003","unstructured":"Sato T, Matsuyama Y (2003) Marginal structural models as a tool for standardization: epidemiology 14(6):680\u2013686. https:\/\/doi.org\/10.1097\/01.EDE.0000081989.82616.7d","journal-title":"Marginal structural models as a tool for standardization: epidemiology"},{"issue":"5","key":"8206_CR26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/resp.12312","volume":"19","author":"EJ Williamson","year":"2014","unstructured":"Williamson EJ, Forbes A (2014) Introduction to propensity scores. Respirology 19(5):625\u2013635. https:\/\/doi.org\/10.1111\/resp.12312","journal-title":"Respirology"},{"issue":"3","key":"8206_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46(3):399\u2013424. https:\/\/doi.org\/10.1080\/00273171.2011.568786","journal-title":"Multivariate Behav Res"},{"issue":"6","key":"8206_CR28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/EDE.0b013e3181ba333c","volume":"20","author":"TJ VanderWeele","year":"2009","unstructured":"VanderWeele TJ (2009) On the distinction between interaction and effect modification. Epidemiology 20(6):863\u2013871. https:\/\/doi.org\/10.1097\/EDE.0b013e3181ba333c","journal-title":"Epidemiology"},{"issue":"408","key":"8206_CR29","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","volume":"84","author":"DY Lin","year":"1989","unstructured":"Lin DY, Wei LJ (1989) The robust inference for the cox proportional hazards model. J Am Stat Assoc 84(408):1074\u20131078. https:\/\/doi.org\/10.1080\/01621459.1989.10478874","journal-title":"J Am Stat Assoc"},{"issue":"16","key":"8206_CR30","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1002\/sim.5705","volume":"32","author":"PC Austin","year":"2013","unstructured":"Austin PC (2013) The performance of different propensity score methods for estimating marginal hazard ratios. Stat Med 32(16):2837\u20132849. https:\/\/doi.org\/10.1002\/sim.5705","journal-title":"Stat Med"},{"key":"8206_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.metip.2021.100076","volume":"5","author":"R Quintana","year":"2021","unstructured":"Quintana R (2021) Thinking within-persons: using unit fixed-effects models to describe causal mechanisms. Methods Psychol 5. https:\/\/doi.org\/10.1016\/j.metip.2021.100076","journal-title":"Methods Psychol"},{"issue":"7","key":"8206_CR32","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G (2004) A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159(7):702\u2013706. https:\/\/doi.org\/10.1093\/aje\/kwh090","journal-title":"Am J Epidemiol"},{"issue":"5","key":"8206_CR33","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1177\/0962280216664760","volume":"27","author":"XR Liu","year":"2018","unstructured":"Liu XR, Pawitan Y, Clements M (2018M) Parametric and penalized generalized survival models. Stat Methods Med Res 27(5):1531\u20131546. https:\/\/doi.org\/10.1177\/0962280216664760","journal-title":"Stat Methods Med Res"},{"issue":"6","key":"8206_CR34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jclinepi.2012.08.008","volume":"66","author":"AF Schmidt","year":"2013","unstructured":"Schmidt AF, Rovers MM, Klungel OH, Hoes AW, Knol MJ, Nielen M et al (2013) Differences in interaction and subgroup-specific effects were observed between randomized and nonrandomized studies in three empirical examples. J Clin Epidemiol 66(6):599\u2013607. https:\/\/doi.org\/10.1016\/j.jclinepi.2012.08.008","journal-title":"J Clin Epidemiol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08206-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08206-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08206-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:36:54Z","timestamp":1790854614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-026-08206-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":34,"alternative-id":["8206"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-08206-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Specifically, Table S7, under the Sensitivity Analyses section, \u201cAlternative Weighting\u201d analysis row, was missing a single row that had been added during the final revision.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Updated supplementary material \u2013 Table S7, Sensitivity Analyses, Alternative Weighting row.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been corrected.","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Zheer K Al-Mashhadi, Veerle van Hulten, Johanna HM Driessen, Peter Vestergaard and S\u00f8ren Gregersen  declare that they have no conflicts of interest. Unrelated to this work, the remaining authors declare the  following:following; Rikke Viggers declares that she holds stock in Eli Lilly and Novo Nordisk; Jakob Starup Linde declares that he is a speaker for UCB Nordic and Gedeon Richter; Bente L Langdahl declares  advisory boards and lecture fees from UCB, Amgen, Gedeon Richter, Sandoz, Samsung-Bioepis, Mereo,  Medivir, Entera-Bio, and Angitia; Joop P van den Bergh has received speaker honorarium from UCB and  honorarium for consultation from Theramex and POROUS.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}